Related Experiment Video
Updated: Jun 2, 2026
10:35
Assessment of Antibody-based Drugs Effects on Murine Bone Marrow and Peritoneal Macrophage Activation
Published on: December 26, 2017
Intravenous immunoglobulin therapy in rheumatic diseases
Jagadeesh Bayry1, Vir Singh Negi, Srini V Kaveri
1Institut National de Santé et de Recherche Médicale Unité 872 (INSERM U872), Université Pierre et Marie Curie and Université René Descartes, 15 rue de l'Ecole de Médicine, Paris, F-75006, France.
Nature Reviews. Rheumatology
|May 11, 2011
Summary
Intravenous immunoglobulin (IVIg) treats immune deficiencies and rheumatic diseases. Further research is needed to optimize IVIg dosage and explore new applications for this valuable therapeutic resource.
Area of Science:
- Immunology
- Rheumatology
- Pharmacology
Background:
- Therapeutic intravenous immunoglobulin (IVIg) is derived from pooled human plasma IgG.
- IVIg is established for immune deficiencies and specific rheumatic conditions like Kawasaki disease and ANCA-positive vasculitis.
Purpose of the Study:
- To review current applications of IVIg in rheumatic diseases.
- To highlight the need for optimized dosing and evidence-based indications for IVIg.
- To suggest future research directions for IVIg therapy.
Main Methods:
- Literature review of IVIg applications in rheumatic diseases.
- Analysis of current IVIg dosage regimens (2 g/kg over 2-5 days).
- Discussion of off-label IVIg use in conditions like lupus erythematosus and polymyositis.
Main Results:
- IVIg is utilized off-label for several rheumatic diseases, lacking robust clinical trial support.
- Current dosage protocols for IVIg are not extensively studied.
- Optimal administration protocols for IVIg require further investigation.
Conclusions:
- Randomized clinical trials are essential to validate IVIg efficacy and establish evidence-based guidelines.
- Research into next-generation immunoglobulin preparations and combination therapies is crucial.
- Optimizing IVIg use is vital due to its limited resource nature.
Related Concept Videos
01:21Rheumatic Heart Disease III: Medical Management
Rheumatic heart disease (RHD) management can be divided into two main strategies: prevention and long-term management.Primary PreventionPrimary prevention focuses on timely diagnosis and management of group A streptococcal pharyngitis to prevent acute rheumatic fever. The most widely used antibiotic for treating this condition is intramuscular benzathine penicillin G.Acute Rheumatic Fever TreatmentThe primary treatment goal for a patient diagnosed with acute rheumatic fever is to suppress the...
01:20Rheumatic Heart Disease IV: Nursing Management
AssessmentA comprehensive assessment is essential in managing a patient with rheumatic heart disease (RHD). Begin with obtaining a detailed medical history, including recent streptococcal infections, a history of rheumatic fever, or previously diagnosed rheumatic heart disease. Assess the patient for symptoms such as fever, chest pain, widespread joint pain (arthralgia), tachycardia, pericardial friction rub, muffled heart sounds, heart murmurs, peripheral edema, subcutaneous nodules, and...
01:24Drugs for Treatment of Crohn's Disease in IBD Using Biologic Agents: Anti-TNF
Tumor Necrosis Factor (TNF), a proinflammatory cytokine, contributes significantly to the inflammation seen in Crohn's disease. It exists as soluble TNF and membrane-bound TNF, with actions mediated through TNF receptors (TNFR). TNFR activation leads to the release of proinflammatory cytokines, T-cell activation, collagen production, and leukocyte migration, all contributing to inflammation in Crohn's disease. Anti-TNF monoclonal antibodies, namely infliximab (Remicade), adalimumab (Humira),...
01:29Respiratory Syncytial Virus Disease
Human respiratory syncytial virus (RSV) is a widespread pathogen that primarily targets infants and young children but also poses a serious health risk to elderly and immunocompromised individuals. Belonging to the Pneumoviridae family, RSV is a negative-sense, single-stranded RNA virus within the Pneumovirus genus. Its global health burden is significant, with millions of cases annually resulting in hospitalizations and mortality, particularly in resource-limited settings. Although most...
01:29Drugs for Treatment of Crohn's Disease in IBD Using Immunomodulatory Agents
Crohn's disease is an inflammatory bowel disorder marked by chronic inflammation of the GI tract. Various treatment strategies for Crohn's disease are employed, such as immunomodulatory agents, glucocorticoids, and biologics or anti-TNF therapy. Azathioprine (Imuran), a commonly used immunomodulatory drug for Crohn's disease, is converted in the body to mercaptopurine, which inhibits purine biosynthesis and cell proliferation. Both are utilized in severe cases of Inflammatory Bowel Disease...
01:29Inflammatory Bowel Disease IV: Pharmacological Management
Upon diagnosis, managing Inflammatory Bowel Disease (IBD) involves addressing several crucial aspects. The primary goals include resting the bowel, correcting malnutrition, and providing symptomatic relief. Resting the bowel may consist of medications to reduce inflammation and promote healing. Correcting malnutrition is essential, often requiring dietary adjustments and nutritional supplements. Symptomatic relief aims to ease pain, diarrhea, and other discomforts in IBD.
Pharmacologic...
Pharmacologic...